Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
---|---|---|---|---|---|---|---|---|
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23127 | TPP | 1/1 | Qing Wen | 5 months, 4 weeks ago 24 May 2024 07:54:20 UTC | View, Job request 23127 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23124 | TPP | 1/1 | Qing Wen | 5 months, 4 weeks ago 23 May 2024 15:18:36 UTC | View, Job request 23124 |
Succeeded | Opioid prescribing trends and changes during COVID-19 | waiting-list | 23117 | TPP | 1/1 | Andrea Schaffer | 6 months ago 22 May 2024 14:24:36 UTC | View, Job request 23117 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23103 | TPP | 1/1 | Qing Wen | 6 months ago 22 May 2024 07:03:14 UTC | View, Job request 23103 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23099 | TPP | 1/1 | Qing Wen | 6 months ago 21 May 2024 19:34:18 UTC | View, Job request 23099 |
Succeeded | Opioid prescribing trends and changes during COVID-19 | waiting-list | 23097 | TPP | 13/13 | Andrea Schaffer | 6 months ago 21 May 2024 16:51:06 UTC | View, Job request 23097 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23094 | TPP | 1/1 | Qing Wen | 6 months ago 21 May 2024 15:53:48 UTC | View, Job request 23094 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23087 | TPP | 1/1 | Qing Wen | 6 months ago 21 May 2024 12:33:04 UTC | View, Job request 23087 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23085 | TPP | 1/1 | Qing Wen | 6 months ago 21 May 2024 11:59:04 UTC | View, Job request 23085 |
Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23083 | TPP | 0/1 | Qing Wen | 6 months ago 21 May 2024 11:31:11 UTC | View, Job request 23083 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23055 | TPP | 1/1 | Qing Wen | 6 months ago 21 May 2024 09:53:57 UTC | View, Job request 23055 |
Succeeded | OpenSAFELY Internal | therapeutics-risk-groups | 23026 | TPP | 1/1 | Becky Smith | 6 months ago 17 May 2024 07:53:48 UTC | View, Job request 23026 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23025 | TPP | 1/1 | Qing Wen | 6 months ago 16 May 2024 15:29:18 UTC | View, Job request 23025 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23023 | TPP | 1/1 | Qing Wen | 6 months ago 16 May 2024 14:52:32 UTC | View, Job request 23023 |
Succeeded | OpenSAFELY Internal | therapeutics-risk-groups | 23020 | TPP | 1/1 | Becky Smith | 6 months ago 16 May 2024 12:26:36 UTC | View, Job request 23020 |
Succeeded | OpenSAFELY Internal | therapeutics-risk-groups | 23019 | TPP | 1/1 | Becky Smith | 6 months ago 16 May 2024 12:10:53 UTC | View, Job request 23019 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23015 | TPP | 1/1 | Qing Wen | 6 months ago 16 May 2024 04:53:24 UTC | View, Job request 23015 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 23014 | TPP | 1/1 | Qing Wen | 6 months, 1 week ago 15 May 2024 20:27:09 UTC | View, Job request 23014 |
Succeeded | OpenSAFELY Internal | therapeutics-risk-groups | 23011 | TPP | 4/4 | Becky Smith | 6 months, 1 week ago 15 May 2024 20:24:41 UTC | View, Job request 23011 |
Failed | Long COVID-19 Sick Notes | long-covid-sick-notes | 23002 | TPP | 30/92 | Rose Higgins | 6 months, 1 week ago 13 May 2024 16:27:12 UTC | View, Job request 23002 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22993 | TPP | 2/2 | Qing Wen | 6 months, 1 week ago 10 May 2024 17:01:09 UTC | View, Job request 22993 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-report | 22989 | TPP | 11/11 | Rose Higgins | 6 months, 1 week ago 09 May 2024 17:08:53 UTC | View, Job request 22989 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22985 | TPP | 1/1 | Qing Wen | 6 months, 1 week ago 09 May 2024 11:27:38 UTC | View, Job request 22985 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22983 | TPP | 1/1 | Qing Wen | 6 months, 1 week ago 09 May 2024 09:20:48 UTC | View, Job request 22983 |
Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | prophy_effects_sotro_molnup | 22981 | TPP | 1/1 | Qing Wen | 6 months, 1 week ago 09 May 2024 08:45:38 UTC | View, Job request 22981 |